Net Loss Per Common Share |
12 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | ||||||||||||||||||||||||||||||||||||
| Net Loss Per Common Share | ||||||||||||||||||||||||||||||||||||
| Net Loss Per Common Share |
12. Net Loss Per Common Share The following potentially dilutive securities outstanding for the years ended September 30, 2022 and 2021 have been excluded from the computation of diluted weighted-average shares outstanding, as they would be anti-dilutive:
|
|||||||||||||||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for earnings per share. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|